skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 5,860  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
Material Type:
Article
Add to My Research

A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa

Science (American Association for the Advancement of Science), 2021-10, Vol.374 (6566), p.423-431 [Peer Reviewed Journal]

Attribution ;ISSN: 0036-8075 ;EISSN: 1095-9203 ;DOI: 10.1126/science.abj4336 ;PMID: 34672751

Digital Resources/Online E-Resources

2
A pooled testing strategy for identifying SARS-CoV-2 at low prevalence
Material Type:
Article
Add to My Research

A pooled testing strategy for identifying SARS-CoV-2 at low prevalence

Nature (London), 2021-01, Vol.589 (7841), p.276-280 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jan 14, 2021 ;ISSN: 0028-0836 ;ISSN: 1476-4687 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2885-5 ;PMID: 33086375

Full text available

3
COVID-19 transmission—up in the air
Material Type:
Article
Add to My Research

COVID-19 transmission—up in the air

The Lancet Respiratory Medicine, 2020-12 [Peer Reviewed Journal]

2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/S2213-2600(20)30514-2

Digital Resources/Online E-Resources

4
Pathological sequelae of long-haul COVID
Material Type:
Article
Add to My Research

Pathological sequelae of long-haul COVID

Nature immunology, 2022-02, Vol.23 (2), p.194-202 [Peer Reviewed Journal]

2022. Springer Nature America, Inc. ;Springer Nature America, Inc. 2022. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-021-01104-y ;PMID: 35105985

Full text available

5
UniProt: the universal protein knowledgebase in 2021
Material Type:
Article
Add to My Research

UniProt: the universal protein knowledgebase in 2021

Nucleic Acids Research, 2021-01, Vol.49 (D1), p.D480-D489 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. 2021 ;The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gkaa1100 ;PMID: 33237286

Digital Resources/Online E-Resources

6
PubChem in 2021: new data content and improved web interfaces
Material Type:
Article
Add to My Research

PubChem in 2021: new data content and improved web interfaces

Nucleic Acids Research, 2021-01, Vol.49 (D1), p.D1388-D1395 [Peer Reviewed Journal]

Published by Oxford University Press on behalf of Nucleic Acids Research 2020. 2021 ;Published by Oxford University Press on behalf of Nucleic Acids Research 2020. ;2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://academic.oup.com/journals/pages/coronavirus . ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gkaa971 ;PMID: 33151290

Digital Resources/Online E-Resources

7
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Material Type:
Article
Add to My Research

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Clinical infectious diseases, 2020-11, Vol.71 (16), p.2027-2034 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa344 ;PMID: 32221519

Full text available

8
Milder disease with Omicron: is it the virus or the pre-existing immunity?
Material Type:
Article
Add to My Research

Milder disease with Omicron: is it the virus or the pre-existing immunity?

Nature reviews. Immunology, 2022-02, Vol.22 (2), p.69-71 [Peer Reviewed Journal]

Springer Nature Limited 2022. ;Springer Nature Limited 2022 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-022-00678-4 ;PMID: 35046570

Full text available

9
Ensembl 2021
Material Type:
Article
Add to My Research

Ensembl 2021

Nucleic Acids Research, 2021-01, Vol.49 (D1), p.D884-D891 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. 2021 ;The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gkaa942 ;PMID: 33137190

Digital Resources/Online E-Resources

10
Viral targets for vaccines against COVID-19
Material Type:
Article
Add to My Research

Viral targets for vaccines against COVID-19

Nature reviews. Immunology, 2021-02, Vol.21 (2), p.73-82 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-020-00480-0 ;PMID: 33340022

Full text available

11
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
Material Type:
Article
Add to My Research

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

Cell, 2023-01, Vol.186 (2), p.279-286.e8 [Peer Reviewed Journal]

2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2022.12.018 ;PMID: 36580913

Full text available

12
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Material Type:
Article
Add to My Research

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

Cell, 2021-04, Vol.184 (9), p.2332-2347.e16 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.03.028 ;PMID: 33761326

Full text available

13
Clinical and Laboratory Predictors of In-hospital Mortality in Patients With Coronavirus Disease-2019: A Cohort Study in Wuhan, China
Material Type:
Article
Add to My Research

Clinical and Laboratory Predictors of In-hospital Mortality in Patients With Coronavirus Disease-2019: A Cohort Study in Wuhan, China

Clinical infectious diseases, 2020-11, Vol.71 (16), p.2079-2088 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com . 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa538 ;PMID: 32361723

Full text available

14
A commentary on 'BF.7 Omicron subvariant (BA.5.2.1.7) posing fears of a rise in COVID-19 cases again: a critical appraisal and salient counteracting strategies'
Material Type:
Article
Add to My Research

A commentary on 'BF.7 Omicron subvariant (BA.5.2.1.7) posing fears of a rise in COVID-19 cases again: a critical appraisal and salient counteracting strategies'

International journal of surgery (London, England), 2024-01, Vol.110 (1), p.582-583 [Peer Reviewed Journal]

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. 2024 ;ISSN: 1743-9159 ;ISSN: 1743-9191 ;EISSN: 1743-9159 ;DOI: 10.1097/JS9.0000000000000766 ;PMID: 37738011

Full text available

15
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
Material Type:
Article
Add to My Research

Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients

The Journal of experimental medicine, 2021-03, Vol.218 (3) [Peer Reviewed Journal]

2020 Rodrigues et al. ;2020 Rodrigues et al. 2020 ;ISSN: 0022-1007 ;EISSN: 1540-9538 ;DOI: 10.1084/JEM.20201707 ;PMID: 33231615

Full text available

16
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
Material Type:
Article
Add to My Research

New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications

New England Journal of Medicine, 2021-05, Vol.384 (19), p.1866-1868 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2100362 ;PMID: 33761203

Digital Resources/Online E-Resources

17
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Material Type:
Article
Add to My Research

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

BMJ (Online), 2022-03, Vol.376, p.e069761-e069761 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj-2021-069761 ;PMID: 35264324

Full text available

18
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Material Type:
Article
Add to My Research

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

BMJ (Online), 2021-03, Vol.372, p.n579-n579 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n579 ;PMID: 33687922

Full text available

19
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Material Type:
Article
Add to My Research

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

New England Journal of Medicine, 2021-08, Vol.385 (7), p.585-594 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2108891 ;PMID: 34289274

Digital Resources/Online E-Resources

20
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
Material Type:
Article
Add to My Research

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

Nature (London), 2022-03, Vol.603 (7902), p.679-686 [Peer Reviewed Journal]

2022. The Author(s). ;Copyright Nature Publishing Group Mar 24, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04411-y ;PMID: 35042229

Full text available

Results 1 - 20 of 5,860  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (5,742)

Refine My Results

Creation Date 

From To
  1. Before 2020  (1)
  2. 2020 To 2020  (938)
  3. 2021 To 2021  (3,722)
  4. 2022 To 2023  (997)
  5. After 2023  (203)
  6. More options open sub menu

Language 

  1. English  (5,854)
  2. Japanese  (874)
  3. Portuguese  (12)
  4. French  (6)
  5. Norwegian  (6)
  6. Spanish  (4)
  7. Chinese  (3)
  8. German  (2)
  9. Korean  (1)
  10. More options open sub menu

Searching Remote Databases, Please Wait